Explore the chemical components of Angong Niuhuang Pill and its potential mechanisms for fever treatment based on UHPLC-Q-Exactive orbitrap HRMS, transcriptomics, and experiment verification.

ETHNOPHARMACOLOGICAL RELEVANCE

Fever is a prevalent clinical symptom and is usually caused by inflammation or infection. Persistent high fever can lead to delirium, coma and convulsions, causing brain damage. Angong Niuhuang Pill (ANP), a traditional Chinese emergency medicine, has been employed in clinical practice for centuries, with well-documented antipyretic effects. However, the molecular mechanisms underlying its temperature-regulating effects remain to be fully elucidated.

AIM OF THE STUDY

This research aimed to analyze the effective components of ANP and examine its therapeutic effects and probable mechanisms on fever.

MATERIALS AND METHODS

In the present study, Chemical constituents of ANP and its blood-absorbed components were identified using UHPLC-Q-Exactive-Orbitrap-MS. Network pharmacology research was employed to investigate the multi-target, multi-pathway mechanisms of ANP therapy for fever. The antipyretic activity of ANP was evaluated using the LPS-induced fever model in rats. The peripheral blood leukocyte counts of the rats were detected using routine blood tests. The levels of TNF-α and IL-6 in serum and the levels of COX-2 and PGE2 in the hypothalamus were measured by enzyme-linked immunosorbent assay (ELISA). Meanwhile, the transcriptome sequencing of rat hypothalamus tissue was utilized to explore the mechanism of antipyretic action at the gene level. Simultaneous immunofluorescence and Western Blot (WB) techniques were used to confirm the expression of various mRNAs and proteins in the hypothalamus, including COX-2, NLRP3, NRF2, TLR4, KEAP1, p-P65, P65, TNF-α and IL-17A. Then, the LPS-Induced RAW264.7 cell model was used to explore the regulatory role of ANP on macrophage polarization phenotype. Protein and mRNA expression levels of iNOS, CD86, and CD206 in RAW264.7 macrophages were evaluated using reverse transcription quantitative polymerase chain reaction (RT-qPCR) and WB analysis.

RESULTS

A total of 169 chemical components were identified in ANP, 13 of which were detected in serum. Network pharmacology research indicated that 13 components in ANP interacted with 91 critical targets to produce their effects. In vivo experiments demonstrated that ANP treatment effectively relieved elevated body temperature and reduced the inflammatory response in rats. The ELISA results showed that all dose groups of ANP could significantly down-regulate the levels of TNF-α and IL-6 in serum, as well as the levels of COX-2 and PGE2 in the hypothalamus. The results of transcriptome sequencing and Western Blot showed that ANP could up-regulate the expression of NRF2 and KEAP1 protein, and down-regulate the expression of TLR4, IL-17A, p-P65/P65, TNF-α, and NLRP3 protein. Meanwhile, ANP significantly inhibited the LPS-induced overproduction of NO, IL-6, and TNF-α inflammatory factors in RAW264.7 cells. Furthermore, ANP suppressed the mRNA and protein expression of iNOS and CD86, enhanced NRF2 protein expression, and reduced p-P65/P65 expression.

CONCLUSION

This work analyzed the intricate chemical constituents of ANP and demonstrated that ANP can efficiently exert antipyretic and anti-inflammatory effects by inhibiting the TLR4/NF-κB/NLRP3 inflammasome axis and activating the NRF2/KEAP1 signaling pathway. The study provided some guidance for subsequent clinical applications and research on ANP.